John Siebert

CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN.

Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA.

Primus Pharmaceuticals, Inc. provides prescription metabolic products to physicians and patients throughout North America. It offers prescription drug and medical food products. Its products include Alcortin A, Novacort, Fosteum, and Limbrel. The company was founded by Michael J. Martin and is headquartered in Scottsdale, AZ.

Accu-Break Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm develops tablets that are designed to improve and enhance the functionality of pharmaceutical tablets. The company was founded in 2001 by Lawrence Solomon and David Lucking headquartered in Plantation, FL.

SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal.

Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.